Shatovisha Dey

Title: Shatovisha Dey: Innovator in Cancer Treatment

Introduction

Shatovisha Dey is a notable inventor based in Danbury, CT (US). He has made significant contributions to the field of cancer treatment through his innovative research and patent. His work focuses on the role of mannan-binding protein-associated serine protease-2 (MASP-2) in cancer, leading to improved treatment methods.

Latest Patents

Shatovisha Dey holds a patent for "Extracellular vesicle derived MASP-2 directed cancer treatment methods." This patent outlines cancer treatment methods that leverage the unexpected discovery of MASP-2 as a biomarker for cancer. The methods involve measuring changes in MASP-2 levels, which can indicate cancer progression, responsiveness to chemotherapy, and remission, particularly in pancreatic cancers. The patent emphasizes the use of extracellular vesicles (EVs) from patient blood samples to provide effective and targeted cancer treatment regimens.

Career Highlights

Shatovisha Dey is associated with Nuvance Health, where he continues to advance his research in cancer treatment. His innovative approach has the potential to transform how cancer is diagnosed and treated, particularly through the use of MASP-2 as a biomarker.

Collaborations

Shatovisha has collaborated with notable colleagues, including Richard C Frank and Deep Siddhartha Pandya. These collaborations have further enriched his research and contributed to the development of effective cancer treatment methods.

Conclusion

Shatovisha Dey's work in cancer treatment exemplifies the impact of innovative research on healthcare. His patent on MASP-2 directed cancer treatment methods represents a significant advancement in the field, offering hope for improved patient outcomes.